metabolic and genetic disorders amyloidosis

66
Metabolic and Genetic Disorders Amyloidosis Etiology • May be primary (idiopathic), secondary to systemic disease, or familial • Formation of a fibrillar protein deposited in soft tissues and visceral organs with associated levels of dysfunction

Upload: cianna

Post on 25-Feb-2016

71 views

Category:

Documents


1 download

DESCRIPTION

Metabolic and Genetic Disorders Amyloidosis. Etiology • May be primary (idiopathic), secondary to systemic disease, or familial • Formation of a fibrillar protein deposited in soft tissues and visceral organs with associated levels of dysfunction. Etiology. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Metabolic and Genetic Disorders Amyloidosis

Metabolic and Genetic DisordersAmyloidosis

Etiology• May be primary (idiopathic), secondary to systemic disease,

orfamilial

• Formation of a fibrillar protein deposited in soft tissues andvisceral organs with associated levels of dysfunction

Page 2: Metabolic and Genetic Disorders Amyloidosis

Etiology

• May be primary (idiopathic), secondary to systemic disease, or familial

• Formation of a fibrillar protein deposited in soft tissues and visceral organs with associated levels of dysfunction

Page 3: Metabolic and Genetic Disorders Amyloidosis

Clinical Presentation• The primary form may produce obvious

tongue enlargement (macroglossia) and associated purpura, or nodular submucosal alterations.

• The secondary form may be subtle; gingival tissues may contain deposits of amyloid.

Page 4: Metabolic and Genetic Disorders Amyloidosis

Diagnosis• Appearance of tongue• Systemic complaints• Biopsy results: demonstration of amyloid

deposits in tissues (tongue, gingiva)

Page 5: Metabolic and Genetic Disorders Amyloidosis

Differential Diagnosis• Hyalinosis cutis et mucosae (lipoid

proteinosis)• Leukemic infiltrate• Lymphangioma• Neurofibromatosis• Hemodialysis-related disorder

Page 6: Metabolic and Genetic Disorders Amyloidosis

Treatment• Directed to underlying cause (secondary)• Localized amyloid tumors may be

excised.• Generally symptom related (dialysis,

digitalis, depending upon organ involvement)

Page 7: Metabolic and Genetic Disorders Amyloidosis

Prognosis• • When renal impairment exists,

transplantation may be necessary.

Page 8: Metabolic and Genetic Disorders Amyloidosis
Page 9: Metabolic and Genetic Disorders Amyloidosis
Page 10: Metabolic and Genetic Disorders Amyloidosis

CherubismEtiology

• Autosomal-dominant, fibroblast/giant cell–containing condition

• May be secondary to somatic mutation, mapping to chromosome 4p16.3

• No associated metabolic or biochemical alterations noted

• Possible linkage/association with Noonan’s syndrome

Page 11: Metabolic and Genetic Disorders Amyloidosis

Clinical Presentation• Early signs in childhood• Bilateral, symmetric enlargement of mandible• Maxillary involvement less common and less

prominent• Dental arch/occlusal discrepancies may be

noted.• Unerupted teeth often noted• Facial features include lower-third fullness and

scleral exposure at a forward resting gaze.

Page 12: Metabolic and Genetic Disorders Amyloidosis

Radiographic Findings• Symmetric, multiloculated, expansile

radiolucencies of mandibular body and ramus

• Impacted/displaced teeth common• Thinned cortices with scalloped medullary

margins• Older patients may exhibit maturation with

bone fill in some areas but with preservation of expanded bony profile.

Page 13: Metabolic and Genetic Disorders Amyloidosis

Diagnosis• Clinical appearance• Radiographic findings

Page 14: Metabolic and Genetic Disorders Amyloidosis

Differential Diagnosis• Central giant cell granuloma (multiple)• Fibrous dysplasia• Langerhans cell disease (histiocytosis X)• Hyperparathyroidism• Multiple odontogenic keratocysts

Page 15: Metabolic and Genetic Disorders Amyloidosis

Treatment• Variable, ranging from cosmetic

recontouring to local curettage early in lesion development

• Active surgical intervention should be deferred until after the pubertal growth spurt, if possible.

Page 16: Metabolic and Genetic Disorders Amyloidosis

Prognosis• Stability usually noted by end of skeletal

growth• Often regresses into adulthood, but

variably so

Page 17: Metabolic and Genetic Disorders Amyloidosis
Page 18: Metabolic and Genetic Disorders Amyloidosis

Candidiasis

Page 19: Metabolic and Genetic Disorders Amyloidosis

Etiology• Infection with a fungal organism of the

Candida species, usually Candida albicans

• Associated with predisposing factors: most commonly, immunosuppression, diabetes mellitus, antibiotic use, or xerostomia

(due to lack of protective effects of saliva)

Page 20: Metabolic and Genetic Disorders Amyloidosis

Clinical Presentation• • Acute (thrush)• • Pseudomembranous• • Painful white plaques representing fungal colonies on• inflamed mucosa• • Erythematous (acute atrophic): painful red patches caused• by acute Candida overgrowth and subsequent stripping of• those colonies from mucosa• • Chronic• • Atrophic (erythematous): painful red patches; organism• difficult to identify by culture, smear, and biopsy• • “Denture-sore mouth”: a form of atrophic candidiasis• associated with poorly fitting dentures; mucosa is red and• painful on denture-bearing surface

Page 21: Metabolic and Genetic Disorders Amyloidosis

Clinical Presentation• • Median rhomboid glossitis: a form of hyperplastic• candidiasis seen on midline dorsum of tongue anterior to• circumvallate papillae• • Perlèche: chronic Candida infection of labial commissures;• often co-infected with Staphylococcus aureus• • Hyperplastic/chronic hyperplastic: a form of hyperkeratosis• in which Candida has been identified; usually buccal• mucosa near commissures; cause and effect not yet proven• • Syndrome associated: chronic candidiasis may be seen in• association with endocrinopathies

Page 22: Metabolic and Genetic Disorders Amyloidosis

Diagnosis• • Microscopic evaluation of lesion smears• • Potassium hydroxide preparation to

demonstrate hyphae• • Periodic acid–Schiff (PAS) stain• • Culture on proper medium (Sabouraud’s, corn

meal, or• potato agar)• • Biopsy with PAS, Gomori’s methenamine silver

(GMS), or• other fungal stain of microscopic sections

Page 23: Metabolic and Genetic Disorders Amyloidosis

Differential Diagnosis• Allergic or irritant contact stomatitis• Atrophic lichen planus

Page 24: Metabolic and Genetic Disorders Amyloidosis

Treatment• Topical or systemic antifungal agents• For immunocompromised patients: routine

topical agents after control of infection is achieved, usually with systemic azole agents

• See “Therapeutics” section• Correction of predisposing factor, if possible• Some cases of chronic candidiasis may require

prolonged therapy (weeks to months).

Page 25: Metabolic and Genetic Disorders Amyloidosis

Prognosis• Excellent in the immunocompetent host

Page 26: Metabolic and Genetic Disorders Amyloidosis

Ecchymosis

Page 27: Metabolic and Genetic Disorders Amyloidosis

Etiology• Soft tissue hemorrhage• Blood dyscrasia with secondary

thrombocytopenia, hemophilia• Vascular wall defects• Coagulopathy• Trauma

Page 28: Metabolic and Genetic Disorders Amyloidosis

Clinical Presentation• Larger than pinpoint spots (ie, larger than

petechiae)• Nonvesicular, macular surface• Lesions do not blanch with pressure• Red to reddish blue to brown color

Page 29: Metabolic and Genetic Disorders Amyloidosis

Diagnosis• Characteristic size, color• History• Blood count, coagulation profile

Page 30: Metabolic and Genetic Disorders Amyloidosis

Differential Diagnosis• Hemophilia, Kaposi’s sarcoma,

hemangioma, thrombocytopenia,von Willebrand’s disease, leukemia, trauma

Page 31: Metabolic and Genetic Disorders Amyloidosis

Treatment• Identification of etiology, and

corresponding treatment

Page 32: Metabolic and Genetic Disorders Amyloidosis

Prognosis• Excellent

Page 33: Metabolic and Genetic Disorders Amyloidosis

Hemangioma

Page 34: Metabolic and Genetic Disorders Amyloidosis

Etiology• Benign developmental anomalies of blood

vessels that may be subclassified as congenital hemangiomas and vascular malformations

• “Congenital hemangioma” usually noted initially in infancy or childhood (hamartomatous proliferation)

• Congenital hemangioma due to proliferation of endothelial cells

• “Vascular malformations” due to abnormal morphogenesis of arterial and venous structures

Page 35: Metabolic and Genetic Disorders Amyloidosis

Clinical Presentation• Congenital lesions usually arise around time of birth, grow rapidly,

and usually involute over several years.• Malformations generally are persistent, grow with the child,and do

not involute.• Color varies from red to blue depending on depth, degree of

congestion, and caliber of vessels• Range in size from few millimeters to massive with disfigurement• Most common on lips, tongue, buccal mucosa• Usually asymptomatic• Sturge-Weber syndrome (trigeminal encephaloangiomatosis)

includes cutaneous vascular malformations (port wine stains) along trigeminal nerve distribution, mental retardation, and seizures.

Page 36: Metabolic and Genetic Disorders Amyloidosis

Diagnosis• Aspiration• Blanching under pressure (diascopy)• Imaging studies

Page 37: Metabolic and Genetic Disorders Amyloidosis

Differential Diagnosis• Purpura• Telangiectasia• Kaposi’s sarcoma• Other vascular neoplasms

Page 38: Metabolic and Genetic Disorders Amyloidosis

Treatment• Observation• Congenital hemangiomas typically involute, whereas

vascular malformations persist.• Surgery (scalpel, cryosurgery, laser [argon, copper])—

congenital hemangiomas usually are circumscribed and more

easily removed than are vascular malformations, which are poorly defined. (Vascular malformations are associated with excessive bleeding and recurrence.)

• Sclerotherapy• Microembolization followed by resection for large

malformations or if bleeding is problematic

Page 39: Metabolic and Genetic Disorders Amyloidosis

Prognosis• Guarded

Page 40: Metabolic and Genetic Disorders Amyloidosis

Petechiae

Page 41: Metabolic and Genetic Disorders Amyloidosis

Etiology• Viral infection (Epstein-Barr virus [EBV]-

mononucleosis;measles), rickettsial infection

• Thrombocytopenia, leukemia• Disseminated intravascular coagulation

(DIC)• Trauma: prolonged coughing, frequent

vomiting, giving birth,fellatio, violent Valsalva maneuvers

Page 42: Metabolic and Genetic Disorders Amyloidosis

Clinical Presentation• Pinpoint hemorrhage into

mucosa/submucosa• Asymptomatic• Usually involves the soft palate• No blanching on pressure (diascopy)

Page 43: Metabolic and Genetic Disorders Amyloidosis

Diagnosis• Clinical features• History, determination of underlying cause

Page 44: Metabolic and Genetic Disorders Amyloidosis

Treatment• None; observation only Prognosis• Variable, depending upon etiology

Page 45: Metabolic and Genetic Disorders Amyloidosis

Plasma Cell Gingivitis

Page 46: Metabolic and Genetic Disorders Amyloidosis

Etiology• Usually represents a hypersensitivity

phenomenon to an agent such as the following:

• Cinnamon/cinnamon flavoring• Candy flavors• Toothpaste/mouthwash• Plaque antigens

Page 47: Metabolic and Genetic Disorders Amyloidosis

Clinical Presentation• Reddened, velvety gingival surface• Surface epithelium becomes

nonkeratinized.• Limited to attached gingiva

Page 48: Metabolic and Genetic Disorders Amyloidosis

Diagnosis• Response to elimination of possible

etiologic agents• Biopsy results show plasma cell infiltration

within the submucosa and lamina propria beneath an acanthotic epithelium.

• Patch testing

Page 49: Metabolic and Genetic Disorders Amyloidosis

Differential Diagnosis• Lupus erythematosus• Wegener’s granulomatosis• Chronic candidiasis• Lichen planus• Mucous membrane pemphigoid

Page 50: Metabolic and Genetic Disorders Amyloidosis

Treatment• Elimination of causative factor Prognosis• Reversal with removal of causative agent

Page 51: Metabolic and Genetic Disorders Amyloidosis

Aphthous Stomatitis

Page 52: Metabolic and Genetic Disorders Amyloidosis

Etiology• • Unknown—probably represents a focal immunodysfunction;• no viral or other infectious agent identified• • Triggers vary from case to case (eg, increased stress/anxiety,• hormonal changes, dietary factors, trauma)• • Alterations in barrier permeability may be a factor, as occur with• human immunodeficiency virus/acquired immunodeficiency• syndrome (HIV/AIDS), bone marrow suppression, neutropenia,• gluten sensitivity, Crohn’s disease, ulcerative colitis, food allergy,• Behçet’s disease, and dietary deficiencies (iron, folate, vitamin• B12, zinc).

Page 53: Metabolic and Genetic Disorders Amyloidosis

Clinical Presentation• • Recurrent, self-limiting, painful ulcers• • Usually restricted to nonkeratinized oral and

pharyngeal• mucosa (not hard palate or attached gingiva)• • Well-demarcated ulcers with yellow fibrinous

base and• erythematous halo• • Three clinical forms: minor ulcers, major ulcers,

herpetiform• lesions

Page 54: Metabolic and Genetic Disorders Amyloidosis

Minor variant (most common subtype)

• Occasional• Single but more often multiple• Less than 1 cm in diameter• Oval to round shape• Healing within 7 to 14 days

Page 55: Metabolic and Genetic Disorders Amyloidosis

Major variant (Sutton’s ulcers)

• 1 cm or greater in diameter• Single or less commonly several• Deep• To ragged edges with elevated edematous

margins• May persist for several weeks to months• Often heal with scarring

Page 56: Metabolic and Genetic Disorders Amyloidosis

Herpetiform variant (least common variant)

• Grouped superficial ulcers 1 to 2 mm in diameter; crops of 10 to 100 lesions

• In nonkeratinized and keratinized tissues• Healing within 7 to 14 days• No etiologic role for herpes simplex virus

Page 57: Metabolic and Genetic Disorders Amyloidosis

Diagnosis• Usually has diagnostic clinical appearance

of focal, welldefined ulcers involving nonkeratinized mucosa

• History helpful; a recurrent process• Positive family history

Page 58: Metabolic and Genetic Disorders Amyloidosis

Differential Diagnosis• Traumatic ulcer• Chancre• Recurrent intraoral herpes simplex

stomatitis• Cyclic neutropenia

Page 59: Metabolic and Genetic Disorders Amyloidosis

Treatment• Symptomatic therapy may be adequate.• Systemic causative factors, if present, should be

addressed.• Tetracycline-based oral rinses may be helpful.• Corticosteroid therapy is the most rational approach and

is a consistently effective treatment.• Topical corticosteroids as gels, creams, or ointment 4 to

6 times/d to early lesions• Intralesional corticosteroid injections• Short-duration systemic corticosteroids (low to moderate

doses)

Page 60: Metabolic and Genetic Disorders Amyloidosis

Prognosis• Simple aphthosis• Excellent• Cannot be cured• Good control with corticosteroids is usually

possible.• Typically, severity decreases as patient ages.• Complex aphthosis• Needs medical evaluation for intercurrent

disease• Chronic problem

Page 61: Metabolic and Genetic Disorders Amyloidosis

Neutropenic Ulcer

Page 62: Metabolic and Genetic Disorders Amyloidosis

Etiology• Idiopathic or iatrogenic neutropenia• Usually noted when neutrophil count falls

below 1,500/mm3

Page 63: Metabolic and Genetic Disorders Amyloidosis

Clinical Presentation• Sharply defined ulcer(s), often with

minimal peripheral erythema• Ulcer base covered by fibrinous exudate• Wide variation in size of ulcers

Page 64: Metabolic and Genetic Disorders Amyloidosis

Diagnosis• Clinical appearance correlated with results

of peripheral blood count

Page 65: Metabolic and Genetic Disorders Amyloidosis

Differential Diagnosis• Major aphthous ulcer• Traumatic ulcer• Necrotizing sialometaplasia• Squamous cell carcinoma

Page 66: Metabolic and Genetic Disorders Amyloidosis

Treatment• Identification and management of

underlying neutropenia• Supportive therapy Prognosis• Relative to ability to manage underlying

neutropenia